Literature DB >> 16291357

Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.

Mariane Rix1, Niels Holtum Birkebaek, Steen Rosthøj, Niels Clausen.   

Abstract

OBJECTIVES: To investigate how frequently adrenal function fails to recover after corticosteroid therapy in children with acute lymphoblastic leukemia and to explore the clinical impact of slow adrenal recovery without steroid substitution. STUDY
DESIGN: Low-dose (1 microg) adrenocorticotropic hormone tests were performed before and after steroid courses and during infectious episodes in 24 children. Test results were not available during the study.
RESULTS: All 13 patients tested before treatment had normal adrenal responses. Adrenal suppression was found in 8 (47%) of 17 patients 5 days after discontinuation of a 5-week induction course of prednisolone and in 1 (20%) of 5 patients 7 days after a 3-week intensification course of dexamethasone, both courses being tapered over 9 days, as well as in all 13 patients tested 2 days after a 1-week prednisolone course. Clinically significant manifestations of adrenal suppression were noted in 3 (12%) patients. Of 204 scheduled tests, 131 were performed.
CONCLUSIONS: High-dose glucocorticoid therapy may cause adrenal suppression lasting more than 1 week in children with acute lymphoblastic leukemia, even after tapering the dose. We suggest steroid replacement during stress episodes within 1 to 2 weeks after discontinuation and thereafter testing adrenal function selectively in accordance with symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291357     DOI: 10.1016/j.jpeds.2005.06.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI.

Authors:  Ruben D de Ruiter; M Suzanne Gordijn; Reinoud J B J Gemke; Cor van den Bos; Marc B Bierings; Joost Rotteveel; Jan W Koper; Elisabeth F C van Rossum; Gertjan L Kaspers
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 2.  What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?

Authors:  Rajesh Aneja; Joseph A Carcillo
Journal:  Arch Dis Child       Date:  2006-09-26       Impact factor: 3.791

Review 3.  Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity.

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

4.  Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.

Authors:  Anasuya Hazra; Nancy Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-26       Impact factor: 2.745

Review 5.  Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.

Authors:  Niki Rensen; Reinoud Jbj Gemke; Elvira C van Dalen; Joost Rotteveel; Gertjan Jl Kaspers
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

Review 6. 

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

7.  Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis.

Authors:  Alexandra Ahmet; Eric I Benchimol; Ellen B Goldbloom; Janice L Barkey
Journal:  Allergy Asthma Clin Immunol       Date:  2016-10-10       Impact factor: 3.406

8.  Screening practices for paediatric asymptomatic adrenal suppression in Canada: Are we addressing this important risk?

Authors:  Ellen B Goldbloom; Alexandra Ahmet
Journal:  Paediatr Child Health       Date:  2019-03-30       Impact factor: 2.253

9.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Authors:  Dora Liu; Alexandra Ahmet; Leanne Ward; Preetha Krishnamoorthy; Efrem D Mandelcorn; Richard Leigh; Jacques P Brown; Albert Cohen; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-15       Impact factor: 3.406

10.  Single serum cortisol values at 09:00 h can be indices of adrenocortical function in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.

Authors:  Masahiro Goto; Naoyuki Miyagawa; Kaori Kikunaga; Masaru Miura; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2015-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.